The current price of CTNM is $8.81 — it has decreased by 10.01% since the previous close. Data as of Nov 5, 2026.
CTNM is down 3.61% over the past week, down 30.74% over the past month and down 15.61% over the past year. The price is below its 200-day moving average of $13.52.
Contineum Therapeutics, Inc. has a market capitalization of $290.37M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Contineum Therapeutics, Inc. posted a loss of $0.49 per share against an estimate of -$0.4538, missing expectations by 7.99%. Upcoming reports are listed in the earnings calendar.
Contineum Therapeutics, Inc. has not paid any dividends over the past year.
In the latest trading session CTNM moved between $8.65 and $9.84, a range of 13.51% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Contineum Therapeutics, Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks CTNM has traded between $6.73 and $17.79. The current price is 50.48% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.